RNA-seq to investigate differentially expressed genes in KPC mouse PDAC treated with CSF-1R small molecule inhibitor AZD7507 and/or the CXCR2 small molecule inhibitor AZD5069

ABSTRACT: Recently, we defined four subtypes of pancreatic cancer that are associated with distinct histopathological characteristics and differential survival, namely, Squamous, Pancreatic Progenitor, Immunogenic, and ADEX (Bailey et al 2016, Nature). We also found that loss of CXCR2 was associated with a switch away from the squamous subtype (Steele et al 2016, Cancer Cell). Here we set out to investigate whether inhibition of CSF1R could also result in an alteration of transcriptomic subtype. Pancreatic tumors were harvested from control KPC mice, or mice treated with CSF1R inhibitor (AZD7507) and/or CXCR2 inhibitor (AZD5069) (n≥5). Tissues were stored in RNAl8r at -80C before RNA was prepared, and RNASeq analysis carried out. Reads were analysed using the bcbio-nextgen framework (https://bcbio-n

INSTRUMENT(S): Illumina HiSeq 2500

ORGANISM(S): Mus musculus

SUBMITTER: Jennifer Morton 

PROVIDER: E-MTAB-6620 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress